Prostatc specific antigen as an indicator of response to radiotherapy in prostate cancerChristine Landmann; Reinhard Hunig · 1989

Pharmacokinetics and immunomodulatory effects on monocytes during prolonged therapy with liposomal muramyltripeptideRegine Landmann; Reto Obrist; Hubert Denz; Christian Ludwig; Heiner Frost; Martin Wesp; Christine Rordorf; Harry Towbin; Daniel Gygax; Lajos Tarcsay; Jean -Paul Obrecht · 1993

Revisiting the specificity of the MHC class II transactivator CIITA in vivoLuc A. Otten; Salomé LeibundGut-Landmann; Joachim Huarte; Isabelle C. Kos-Braun; Christine Lavanchy; Emmanuèle Barras; Bettina Borisch; Viktor Steimle; Hans Acha-Orbea; Walter Reith · 2006

Adverse effect of transurethral resection on disease-free survival in locally advanced prostatic cancer treated with irradiationChristine Landmann; Reinhard Hunig; Georg Rutishauser · 1993

Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network studyDavid Knobel; Abderrahim Zouhair; Richard W Tsang; Philip Poortmans; Yazid Belkacémi; Michel Bolla; Dinçbas Fazilet Oner; Christine Landmann; Bernard Castelain; Mahmut Ozsahin; for the Rare Cancer Network · 2006

Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancerArvin S. Glicksman; Harold J. Wanebo; Gus Slotman; Li Liu; Christine Landmann; Jeffrey Clark; Timothy C. Zhu; Andreas Lohri; Rudolf Probst · 1997

Combined chemoradiotherapy with daily low-dose cisplatin in locally advanced inoperable non-small cell lung cancerBeat Biedermann; Christine Landmann; Roger Kann; Jakob Passweg; Markus Solèr; Andreas Lohri; Christoph Rochlitz; Richard Herrmann; Miklos Pless · 2000